HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding
Not yet recruiting
- Conditions
- Upper Gastrointestinal Bleeding
- Registration Number
- NCT07114042
- Lead Sponsor
- Sohag University
- Brief Summary
Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.
- Detailed Description
Study for evaluation of the utility of hemoglobin, Albumin, Lymphocyte and Platelat score in prediction of mortality and re_bleeding in patient with upper gastrointestinal bleeding, Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.
Exclusion Criteria
- Incomplete clinical data.
- Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).
- Pregnancy
- Patients with missing data on clinical outcomes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method "Mortality" 6 months Incidence of "Re_bleeding" 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Faculty of Medicine -Sohag university
🇪🇬Sohag, Egypt
Faculty of Medicine -Sohag university🇪🇬Sohag, EgyptReham R Baeoumy, MasterPrincipal Investigator